Dube Eric M's Form 4 filing
Travere Therapeutics, Inc. (TVTX) · filed Sep 9, 2024
- Accession no.
- 0001415889-24-023094
- Filed
- Sep 9, 2024
- Trade date
- Sep 5-9, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $243.4K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dube Eric MCIK 0001763494 | Director, Officer (CHIEF EXECUTIVE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 5, 2024 | Common Stock | AGrant or awardAcquired | +32,500 | $0.00 | $0 | 383,100 | Direct | |
| Sep 9, 2024 | Common Stock | SSaleDisposed | −21,125 | $11.52 | −$243,360 | 361,975 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.